Poseida Therapeutics, Inc. (PSTX)
Largest Insider Buys in Sector
PSTX Stock Price History Chart
PSTX Stock Performance
About Poseida Therapeutics, Inc.
Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant prostate cancer (mCRPC). It is also developing P-BCMA-ALLO1, which is in Phase I trial to treat patients with relapsed/refractory multiple myeloma; and P-MUC1C-ALLO1 that is in Phase I trial for treating a range of solid tumors, including breast, ovarian, and other epithelial-derived cancers. In addition, the company engages in the development of P-CD19CD20-ALLO1 for B cell malignancies and other autoimmune diseases; and P-BCMACD19-ALLO1, an allogeneic, off-the-shelf CAR-T product candidate in preclinical development for multiple myeloma. Further, it is developing P-PSMA-ALLO1, an allogeneic CAR-T product candidate for treating mCRPC. Additionally, the company engages in the development of P-OTC-101 and P-FVIII-101 that are clinical stage liver-directed gene therapies; and other allogeneic dual CAR candidates. It has a research collaboration and license agreement with Takeda Pharmaceutical Company Limited. The company was incorporated in 2014 and is headquartered in San Diego, California.
Insider Activity of Poseida Therapeutics, Inc.
Over the last 12 months, insiders at Poseida Therapeutics, Inc. have bought $0 and sold $0 worth of Poseida Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Poseida Therapeutics, Inc. have bought $6.75M and sold $4.7M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 2,150,000 shares for transaction amount of $7.53M was made by Malin Life Sciences Holdings Ltd () on 2022‑08‑08.
List of Insider Buy and Sell Transactions, Poseida Therapeutics, Inc.
| 2022-08-08 | Malin Life Sciences Holdings Ltd | 2.15M 2.6659% | $3.50 | $7.53M | +0.14% | |||
| 2022-08-08 | Ostertag Eric | Executive Chairman | 142,857 0.1771% | $3.50 | $500,000 | +0.14% | ||
| 2022-08-03 | Sale | Ostertag Eric | Executive Chairman | 160,696 0.1723% | $3.69 | $592,808 | -17.29% | |
| 2022-03-16 | Ingalls Kerry D. | Chief Operating Officer | 3,000 0.0048% | $3.98 | $11,940 | +3.27% | ||
| 2021-12-06 | Malin Life Sciences Holdings Ltd | 10 percent owner | 1,828 0.003% | $6.90 | $12,613 | -43.32% | ||
| 2021-12-02 | Malin Life Sciences Holdings Ltd | 10 percent owner | 4,296 0.0065% | $6.88 | $29,550 | -47.09% | ||
| 2021-12-01 | Malin Life Sciences Holdings Ltd | 10 percent owner | 18,365 0.0295% | $6.85 | $125,806 | -44.07% | ||
| 2021-11-30 | Malin Life Sciences Holdings Ltd | 10 percent owner | 28,592 0.0451% | $6.85 | $195,838 | -45.04% | ||
| 2021-11-29 | Malin Life Sciences Holdings Ltd | 10 percent owner | 11,057 0.0177% | $6.89 | $76,209 | -44.56% | ||
| 2021-11-26 | Malin Life Sciences Holdings Ltd | 10 percent owner | 27,251 0.0433% | $6.81 | $185,492 | -44.23% | ||
| 2021-11-24 | Malin Life Sciences Holdings Ltd | 10 percent owner | 1,054 0.0016% | $6.89 | $7,260 | -46.80% | ||
| 2021-11-23 | Malin Life Sciences Holdings Ltd | 10 percent owner | 14,625 0.0227% | $6.77 | $98,989 | -45.35% | ||
| 2021-11-19 | Malin Life Sciences Holdings Ltd | 10 percent owner | 11,104 0.0174% | $7.44 | $82,650 | -49.74% | ||
| 2021-11-18 | Malin Life Sciences Holdings Ltd | 10 percent owner | 71,312 0.1129% | $7.18 | $511,685 | -47.31% | ||
| 2021-11-17 | Malin Life Sciences Holdings Ltd | 10 percent owner | 280,384 0.4549% | $7.21 | $2.02M | -46.27% | ||
| 2021-11-17 | Ingalls Kerry D. | Chief Operating Officer | 2,000 0.0032% | $7.00 | $14,000 | -46.27% | ||
| 2021-11-16 | Malin Life Sciences Holdings Ltd | 10 percent owner | 27,680 0.0441% | $7.17 | $198,383 | -46.87% | ||
| 2021-11-08 | Sale | Ostertag Eric | Chief Executive Officer | 18,924 0.0324% | $7.09 | $134,171 | -42.30% | |
| 2021-10-01 | Sale | Ostertag Eric | Chief Executive Officer | 20,029 0.0319% | $7.02 | $140,604 | -43.97% | |
| 2021-09-20 | Sale | Ostertag Eric | Chief Executive Officer | 20,000 0.0322% | $8.00 | $160,020 | -47.62% |
Insider Historical Profitability
| Malin Life Sciences Holdings Ltd | 11835673 12.3773% | $2.47 | 13 | 0 | <0.0001% | |
| Hirsch David | director | 2714245 2.8384% | $2.47 | 1 | 0 | <0.0001% |
| Ostertag Eric | Executive Chairman | 838824 0.8772% | $2.47 | 1 | 22 | +0.14% |
| Ingalls Kerry D. | Chief Operating Officer | 55000 0.0575% | $2.47 | 2 | 0 | <0.0001% |
| Spear Matthew A. | Chief Medical Officer | 41485 0.0434% | $2.47 | 0 | 3 | |
| Murphy Sean | 10000 0.0105% | $2.47 | 1 | 0 | <0.0001% | |
| Lloyd Marcea Bland | director | 10000 0.0105% | $2.47 | 1 | 0 | <0.0001% |
Institutional Investor Ownership
| Fidelity Investments | $46.17M | 14.93 | 14.47M | +0.9% | +$413,755.76 | <0.01 | |
| Hudson Bay Capital Management LP | $19.06M | 6.16 | 5.97M | 0% | +$0 | 0.5 | |
| BlackRock | $15.79M | 5.11 | 4.95M | -1.61% | -$258,718.57 | <0.0001 | |
| Boxer Capital, LLC | $14.28M | 4.62 | 4.47M | New | +$14.28M | 0.71 | |
| Silverarc Capital Management Llc | $11.47M | 3.71 | 3.6M | -2.95% | -$348,676.56 | 3.38 | |
| The Vanguard Group | $10.76M | 3.48 | 3.37M | +16.34% | +$1.51M | <0.0001 | |
| Geode Capital Management | $4.99M | 1.61 | 1.56M | +2.65% | +$128,587.45 | <0.0001 | |
| State Street | $4.63M | 1.5 | 1.45M | +5.18% | +$227,963.76 | <0.0001 | |
| Aisling Capital Management LP | $3.33M | 1.08 | 1.04M | 0% | +$0 | 1.14 | |
| Blair William Co Il | $3.08M | 1 | 965,052 | +41.35% | +$900,568.94 | 0.01 | |
| Jacobs Levy Equity Management | $2.65M | 0.86 | 830,127 | +89.39% | +$1.25M | 0.01 | |
| Octagon Capital Advisors LP | $2.35M | 0.76 | 736,000 | New | +$2.35M | 0.31 | |
| Millennium Management LLC | $2.08M | 0.67 | 653,413 | +10.27% | +$194,063.61 | <0.01 | |
| Atom Investors Lp | $1.98M | 0.64 | 619,674 | +74.25% | +$842,344.99 | 0.25 | |
| Dimensional Fund Advisors | $1.88M | 0.61 | 590,140 | +21.13% | +$328,375.30 | <0.01 | |
| Northern Trust | $1.78M | 0.58 | 558,395 | +0.7% | +$12,310.21 | <0.0001 | |
| Renaissance Technologies | $1.78M | 0.58 | 557,400 | +5.15% | +$87,081.81 | <0.01 | |
| Charles Schwab | $1.7M | 0.55 | 532,593 | +4.48% | +$72,827.71 | <0.0001 | |
| Connor Clark & Lunn Investment Management Ltd | $1.61M | 0.52 | 503,760 | +34.51% | +$412,269.12 | <0.01 | |
| Morgan Stanley | $1.49M | 0.48 | 468,576 | +37.16% | +$404,929.72 | <0.0001 | |
| Goldman Sachs | $1.44M | 0.47 | 450,517 | -4.34% | -$65,251.49 | <0.0001 | |
| Acadian Asset Management | $1.17M | 0.38 | 365,518 | -27.15% | -$434,107.66 | <0.01 | |
| Wellington Management Company | $1.14M | 0.37 | 356,896 | New | +$1.14M | <0.0001 | |
| Jane Street Capital | $1.05M | 0.34 | 329,920 | +1,019.02% | +$958,394.21 | <0.01 | |
| Nuveen | $868,277.00 | 0.28 | 272,187 | -3.69% | -$33,316.38 | <0.0001 | |
| MCF Advisors | $788,008.00 | 0.26 | 247,024 | 0% | +$0 | 0.06 | |
| BNY Mellon | $645,605.00 | 0.21 | 202,384 | -11.99% | -$87,967.45 | <0.0001 | |
| Bank of America | $588,128.00 | 0.19 | 184,366 | -22.41% | -$169,880.39 | <0.0001 | |
| Bridgeway Capital Management | $458,084.00 | 0.15 | 143,600 | -29.68% | -$193,314.00 | 0.01 | |
| Ameriprise Financial | $419,491.00 | 0.14 | 131,502 | +250.54% | +$299,821.45 | <0.0001 | |
| Ohio Strs | $356,000.00 | 0.12 | 111,600 | +455.22% | +$291,881.72 | <0.01 | |
| DekaBank | $302,000.00 | 0.1 | 100,000 | 0% | +$0 | <0.01 | |
| RhumbLine Advisers | $297,102.00 | 0.1 | 93,137 | +4.43% | +$12,616.24 | <0.0001 | |
| Xtx Topco Ltd | $289,174.00 | 0.09 | 90,650 | +518.1% | +$242,389.38 | 0.02 | |
| Artia Global Partners Lp | $274,346.00 | 0.09 | 86,002 | New | +$274,346.00 | 0.07 | |
| American Century Investments | $272,630.00 | 0.09 | 85,464 | +69.06% | +$111,362.84 | <0.0001 | |
| Man Group Plc | $254,042.00 | 0.08 | 79,637 | New | +$254,042.00 | <0.01 | |
| Cornercap Investment Counsel Inc | $253,771.00 | 0.08 | 79,552 | 0% | +$0 | 0.04 | |
| Callan Capital | $250,670.00 | 0.08 | 78,580 | +2.64% | +$6,446.98 | 0.03 | |
| JPMorgan Chase | $250,495.00 | 0.08 | 78,525 | +70.25% | +$103,362.48 | <0.0001 | |
| ExodusPoint Capital Management, LP | $245,000.00 | 0.08 | 76,686 | New | +$245,000.00 | <0.01 | |
| Barclays | $240,000.00 | 0.08 | 75,345 | -37.9% | -$146,500.50 | <0.0001 | |
| Cantor Fitzgerald L P | $239,904.00 | 0.08 | 75,205 | +49.8% | +$79,750.02 | 0.01 | |
| UBS | $240,353.00 | 0.08 | 75,346 | +12.54% | +$26,776.78 | <0.0001 | |
| RBF Capital, LLC | $223,845.00 | 0.07 | 70,171 | 0% | +$0 | 0.01 | |
| Citadel Advisors LLC | $205,512.00 | 0.07 | 64,424 | New | +$205,512.00 | <0.0001 | |
| Public Employees Retirement System Of Ohio | $200,795.00 | 0.07 | 62,945 | +177.29% | +$128,381.84 | <0.01 | |
| Balyasny Asset Management Llc | $181,310.00 | 0.06 | 56,837 | New | +$181,310.00 | <0.0001 | |
| HSBC | $180,985.00 | 0.06 | 56,735 | +15.8% | +$24,700.22 | <0.0001 | |
| Johnson Investment Counsel Inc | $149,158.00 | 0.05 | 46,758 | 0% | +$0 | <0.01 |